We are live on
!
Find out more
PA
PharVision Advisers Portfolio holdings
AUM
$9.86M
1-Year Est. Return
9.93%
This Fund
S&P 500
This Quarter
Est. Return
+0.93%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$198M
AUM Growth
+$19.8M
(+11%)
Cap. Flow
+$23.3M
Cap. Flow
% of AUM
11.78%
Top 10 Holdings %
Top 10 Hldgs %
3.45%
Holding
1,063
New
409
Increased
141
Reduced
117
Closed
396
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Delek US
DK
|
+$871K |
| 2 |
Broadcom
AVGO
|
+$691K |
| 3 |
Agilent Technologies
A
|
+$650K |
| 4 |
Telos
TLS
|
+$640K |
| 5 |
Pagaya Technologies
PGY
|
+$627K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Array Technologies
ARRY
|
+$730K |
| 2 |
Vertiv
VRT
|
+$639K |
| 3 |
Zevra Therapeutics
ZVRA
|
+$635K |
| 4 |
BOW
Bowhead Specialty Holdings
BOW
|
+$608K |
| 5 |
Rigel Pharmaceuticals
RIGL
|
+$581K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Industrials | 15.13% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 11.79% |
| 5 | Healthcare | 11.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Helix Energy Solutions
HLX
$1.35B
| $285K | 0.14% |
+45,423
| New | +$302K |
|
|
NTST
302
NETSTREIT Corp
NTST
$2.13B
| $285K | 0.14% |
+16,134
| New | +$294K |
|
303
CRH
CRH
$69.1B
| $285K | 0.14% |
+2,280
| New | +$272K |
|
304
Trade Desk
TTD
$8.89B
| $284K | 0.14% |
+7,486
| New | +$332K |
|
305
Bank of Hawaii
BOH
$3.17B
| $284K | 0.14% |
4,148
+941
| +29% | +$62K |
|
306
Helmerich & Payne
HP
$3.31B
| $284K | 0.14% |
+9,886
| New | +$263K |
|
307
Mueller Water Products
MWA
$4.05B
| $284K | 0.14% |
11,903
-556
| -4% | -$13.8K |
|
308
Haemonetics
HAE
$3.75B
| $283K | 0.14% |
+3,537
| New | +$238K |
|
309
OGE Energy
OGE
$10.2B
| $282K | 0.14% |
6,614
+675
| +11% | +$30.1K |
|
310
Spectrum Brands
SPB
$2.08B
| $280K | 0.14% |
4,735
-1,069
| -18% | -$60.1K |
|
311
Eli Lilly
LLY
$1.09T
| $279K | 0.14% |
+260
| New | +$249K |
|
312
Cal-Maine
CALM
$4.42B
| $279K | 0.14% |
3,510
-88
| -2% | -$7.73K |
|
313
Kodak
KODK
$812M
| $279K | 0.14% |
33,011
+20,259
| +159% | +$151K |
|
314
Magnolia Oil & Gas
MGY
$5.55B
| $279K | 0.14% |
+12,753
| New | +$290K |
|
315
O'Reilly Automotive
ORLY
$75.6B
| $279K | 0.14% |
+3,060
| New | +$299K |
|
|
ACH
316
Accendra Health
ACH
$249M
| $279K | 0.14% |
107,865
+84,578
| +363% | +$302K |
|
|
OLP
317
One Liberty Properties
OLP
$547M
| $279K | 0.14% |
+13,742
| New | +$284K |
|
318
Mine Safety
MSA
$6.94B
| $279K | 0.14% |
+1,740
| New | +$283K |
|
319
PC Connection
CNXN
$2.1B
| $279K | 0.14% |
4,824
-2,590
| -35% | -$154K |
|
320
Hamilton Lane
HLNE
$3.91B
| $279K | 0.14% |
+2,074
| New | +$261K |
|
321
McEwen Inc
MUX
$1.03B
| $278K | 0.14% |
+14,999
| New | +$279K |
|
322
ICL Group
ICL
$6.76B
| $277K | 0.14% |
+48,594
| New | +$281K |
|
323
China Yuchai International
CYD
$1.74B
| $277K | 0.14% |
+7,807
| New | +$285K |
|
324
Smith & Wesson
SWBI
$657M
| $277K | 0.14% |
+28,075
| New | +$271K |
|
325
Newmark Group
NMRK
$2.88B
| $277K | 0.14% |
+15,964
| New | +$280K |
|
Similar funds
BS
RG
MP
CCM
DFA
CCP
FRT
VH
PharVision Advisers's Q4 2025 Portfolio in Review
As of Q4 2025, PharVision Advisers held 1,063 positions worth $198M, up 11% from $178M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.
PharVision Advisers deployed $23.3M of net new capital in Q4 2025, opening 409 new positions and adding to 141 existing holdings. Its largest new stake was Delek US: 24,407 shares worth $724K.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Wayfair, an estimated $510K trimmed.
- PharVision Advisers's largest Q4 2025 buy was Delek US: 24,407 shares worth $724K.
- PharVision Advisers added most to NIO in Q4 2025, an estimated $557K increase.
- PharVision Advisers's biggest Q4 2025 reduction was Wayfair, cutting an estimated $510K.
- PharVision Advisers fully exited Array Technologies in Q4 2025, selling an estimated $730K.
- PharVision Advisers's ten largest holdings make up 3.5% of its $198M portfolio in Q4 2025.
- PharVision Advisers opened 409 new positions and closed 396 in Q4 2025.
- PharVision Advisers's portfolio value rose 11% quarter-over-quarter to $198M.
Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.